Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 39.65B | 23.47% |
| Other nonoperating income (expense) | revenue | 34.00M | -79.14% |
| Income from operations | profit | 1.75B | -12.91% |
| Total operating expenses | cost | 37.89B | 25.90% |
| Aggregate | revenue | 1.79B | |
| Benefits | cost | 33.71B | 27.03% |
| Operating costs | cost | 4.02B | 19.05% |
| Depreciation and amortization | cost | 163.00M | -10.93% |
| Income before income taxes and equity in net losses | profit | 1.59B | -5.68% |
| Interest expense | cost | 193.00M | 20.62% |
| Net income (loss) attributable to noncontrolling interest | cost | 2.00M | 0.00% |
| Net income | profit | 1.18B | -4.67% |
| Provision for income taxes | cost | 395.00M | -2.71% |
| Equity in net losses | revenue | 16.00M | -62.79% |
| Net income attributable to humana | profit | 1.19B | -4.66% |
| Segment | Value | YoY |
|---|---|---|
| Insurance | 38.06B | 23.02% |
| CenterWell | 6.10B | 19.73% |
| Segment | Value | YoY |
|---|---|---|
| External Revenues | 39.39B | 23.67% |
| Others | 262.00M | -0.76% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Investment securities | assets | 17.01B | |
| Other current assets | assets | 10.90B | |
| Receivables, net of allowances of $102 in 2026 and $108 in 2025 | assets | 5.22B | |
| Cash and cash equivalents | assets | 4.95B | |
| Total current assets | assets | 38.08B | |
| Goodwill | assets | 10.49B | |
| Other long-term assets | assets | 3.28B | |
| Property and equipment, net | assets | 2.17B | |
| Equity method investments | assets | 633.00M | |
| Long-term investment securities | assets | 626.00M | |
| Total assets | assets | 55.28B | |
| Total liabilities | liabilities | 36.63B | |
| Total equity | liabilities | 18.65B | |
| Total current liabilities | liabilities | 21.51B | |
| Long-term debt | liabilities | 12.27B | |
| Other long-term liabilities | liabilities | 2.85B | |
| Noncontrolling interests | liabilities | 66.00M | |
| Total stockholders' equity | equity | 18.58B | |
| Treasury stock, common, value | equity | 14.52B | |
| Accumulated other comprehensive loss | equity | 731.00M | |
| Benefits payable | liabilities | 12.69B | |
| Trade accounts payable and accrued expenses | liabilities | 6.53B | |
| Short-term debt | liabilities | 1.72B | |
| Book overdraft | liabilities | 297.00M | |
| Unearned revenues | liabilities | 269.00M | |
| Aggregate | equity | 33.83B | |
| Retained earnings | equity | 30.15B | |
| Capital in excess of par value | equity | 3.64B | |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,719,832 shares issued at march 31, 2026 and 198,719,321 shares issued at december 31, 2025 | equity | 33.00M |
| Item | Value |
|---|---|
| Benefits payable | 2.72B |
| Net income | 1.18B |
| Other liabilities | 452.00M |
| Depreciation | 183.00M |
| Stock-based compensation | 51.00M |
| Other, net | 21.00M |
| Equity in net losses | 16.00M |
| Amortization | 11.00M |
| Impairment of property and equipment | 2.00M |
| Net recognized (losses) gains on investment securities | 1.00M |
| Unearned revenues | -87.00M |
| Increase (decrease) in other operating assets | -1.39B |
| Increase (decrease) in receivables | -1.91B |
| Item | Value |
|---|---|
| Proceeds from maturities of investment securities | 923.00M |
| Proceeds from sales of investment securities | 395.00M |
| Increase (decrease) in collateral held under securities lending | 55.00M |
| Payments to acquire property, plant, and equipment | -121.00M |
| Acquisitions, net of cash acquired | -911.00M |
| Payments to acquire debt securities, available-for-sale | -2.89B |
| Item | Value |
|---|---|
| Proceeds from issuance of notes, net | 990.00M |
| Proceeds (repayments) from issuance of commercial paper, net | 693.00M |
| Payments for (proceeds from) contract deposits | 673.00M |
| Change in book overdraft | -9.00M |
| Repayments of notes | -10.00M |
| Other | -18.00M |
| Changes in securities lending payable | -55.00M |
| Payments for repurchase of common stock | -107.00M |
| Payments of dividends | -107.00M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 4.20B |
| Cash and cash equivalents, end of period | 4.95B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support